September 2011 – Policy & Medicine

CME Coalition: Congressional Briefing on HIV and CME

CME Coalition Congressional Briefing on Breast Cancer and CME

FDA Guidance on Informed Consent

FDA Biosimilars Guidance Coming Soon

CMS Rules for Values Based Purchasing

Affordable Care Act Medical Device Fee’s Cause of 11% Jobs Loss

FDA Draft Guidance – Oversight of Clinical Investigations: A Risk Based Approach to Monitoring

Elimination of Industry Support for CME an Urban Myth

Alliance for Continuing Medical Education Moving Ahead with National Faculty Disclosure System

FDA Revises Guidance on Marketed Unapproved Drugs – Enforcement Actions without Notice